ARDELYX, INC. Other Current Liabilities
ARDELYX, INC. (ARDX) had Other Current Liabilities of $7.35 million as of 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-02-19
- 2025-12-31: Other Liabilities, Current $7.35M.
- 2024-12-31: Other Liabilities, Current $6.54M; Other Liabilities, Current as first filed $8.76M.
- 2023-12-31: Other Liabilities, Current $4.88M; Other Liabilities, Current as first filed $1.37M.
- 2022-12-31: Other Liabilities, Current $885.00K.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2025-12-31 | $7.35M 10-K · filed 2026-02-19 | |
| 2024-12-31 | $6.54M 10-K · filed 2026-02-19 | $8.76M 10-K · filed 2025-02-20 |
| 2023-12-31 | $4.88M 10-K · filed 2025-02-20 | $1.37M 10-K · filed 2024-02-22 |
| 2022-12-31 | $885.00K 10-K · filed 2024-02-22 | |
| 2021-12-31 | $474.00K 10-K · filed 2023-03-02 | $605.00K 10-K · filed 2022-02-28 |
| 2020-12-31 | $285.00K 10-K · filed 2022-02-28 | |
| 2019-12-31 | $749.00K 10-K · filed 2021-03-08 | |
| 2019-09-30 | $170.00K 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $222.00K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $211.00K 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $378.00K 10-K · filed 2020-03-06 | $399.00K 10-K · filed 2019-03-06 |
| 2018-09-30 | $976.00K 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $844.00K 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $984.00K 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $752.00K 10-K · filed 2019-03-06 | |
| 2017-09-30 | $700.00K 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $855.00K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $647.00K 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $684.00K 10-K · filed 2018-03-14 | |
| 2016-09-30 | $824.00K 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $771.00K 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $539.00K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $380.00K 10-K · filed 2017-02-17 | |
| 2015-09-30 | $845.00K 10-Q · filed 2015-11-12 | |
| 2014-12-31 | $780.00K 10-Q · filed 2015-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |